Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
AIM ImmunoTech Inc logo

AIM ImmunoTech Inc

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

0.50
 
USD
  
0.01
  
(2.12%)
Optionable: No  Market Cap: 25 M  90-day average vol: 226,930

Previous close: 0.4848  Open: 0.48  Bid: 0.49  Ask: 0.5
52 week range    
0.32   
   0.75
Peers   
OMHE / 
OILS-CA / 
OGN / 
Last updated: Wednesday 17th April 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

OGN

0.03348 B5.333.52

OILS-CA

OMHE

ONPH

0 B4.44
Financials

AIM Income Statement

Annual
Dec-12Dec-13Dec-14Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles-56000.0-22000.0-57000.068000.0116000.0218000.0
Basic EPS from continuing operations-0.45-0.4-0.4
Basic EPS total-0.45-0.4-0.4
Basic weighted shares outstanding3 M4 M4 M495868.0651729.01 M4 M32 M47 M48 M
Cost of sales-2 M-1 M1 M1 M1 M884000.0893000.0806000.0850000.0
Depreciation665000.0659000.038000.0
Depreciation unreconciled-582000.0
DepreciationAndAmortization-582000.0665000.0659000.038000.0
Diluted EPS total-5.28-4.4-3.96-14.96-12.76-9.68-2.58-0.45-0.4-0.4
Diluted normalized net income/share-2.58
Diluted weighted shares outstanding3 M4 M4 M501470.0681504.01 M4 M32 M47 M48 M
Earnings from equity interest14000.0388000.0135000.0
EarningsFromEquityInterestNetOfTax14000.0388000.0135000.0
GainOnSaleOfBusiness85000.0
GainOnSaleOfPPE223000.0216000.03000.0
GainOnSaleOfSecurity331000.0-871000.0-160000.011000.014000.03000.0219000.0-201000.0-2 M
GeneralAndAdministrativeExpense9 M8 M9 M8 M7 M6 M7 M9 M9 M13 M
Gross operating profit-2 M-803000.0-1 M-1 M-746000.0-884000.0-753000.0-643000.0-715000.0141000.0
ImpairmentOfCapitalAssets859000.0135000.02 M
Income before tax-18 M-18 M-19 M-10 M-9 M-11 M-13 M-16 M-21 M-21 M
Income taxes-105000.0-2 M
Interest income665000.0129000.088000.0
InterestExpenseNonOperating24000.016000.011000.0-201000.0427000.0672000.067000.0
InterestIncomeOperating2 M791000.0665000.0
MiscOtherSpecialCharges2 M775000.014000.02 M2 M1 M1 M19000.0-3 M664000.0
Net income from total operations-17 M-17 M-17 M-8 M-8 M-11 M-14 M-14 M-19 M-19 M
NetIncomeCommonStockholders-17 M-17 M-17 M-8 M-8 M-11 M-14 M-14 M-19 M-19 M
NetIncomeContinuousOperations-17 M-17 M-17 M-8 M-8 M-11 M-14 M-14 M-19 M-19 M
NetIncomeFromOtherGainsLosses1 M686000.01 M3 M879000.032000.0-726000.01 M2 M1 M
NetNonOperatingInterestIncomeExpense-24000.0-16000.0654000.0129000.0-139000.0-502000.0-427000.0-672000.0-67000.0
NonRecurringOperationExpense-474000.01 M
Operating income-20 M-17 M-19 M-12 M-11 M-11 M-12 M-15 M-19 M-20 M
Operating income before depreciation (EBITDA)-18 M-17 M-17 M-9 M-8 M-9 M-11 M-14 M-21 M-21 M
OperatingExpense19 M16 M18 M11 M11 M10 M12 M14 M16 M20 M
Other income net-322000.02 M131000.0-2 M-2 M-1 M-1 M-238000.03 M1 M
Other special charges90000.0
OtherGandA9 M8 M9 M8 M7 M6 M7 M9 M9 M13 M
OtherImpairmentOfCapitalAssets9000.0800000.0145000.0135000.02 M2 M
OtherOperatingExpenses-30000.0
OtherTaxes-2 M
PromotionAndAdvertising776000.0
RentAndLandingFees9 M8 M9 M8 M7 M6 M-59000.0-53000.0-67000.0-190000.0
Research & development expense10 M8 M9 M5 M4 M5 M5 M6 M8 M7 M
ResearchExpense10 M8 M9 M5 M4 M5 M5 M6 M8 M7 M
Revenue per share-56000.0-582000.0-57000.068000.0116000.0218000.0
SalariesAndWages-3 M-2 M-86000.0-929000.0-853000.01 M2 M954000.0
Selling Gen & administrative expense9 M8 M9 M8 M7 M6 M7 M9 M9 M13 M
SellingAndMarketingExpense776000.0
Special income/charges-385000.0-1 M-135000.0-2 M
Total Income available for interest expense (EBIT)-18 M-18 M-19 M-10 M-9 M-10 M-12 M-15 M-21 M-21 M
Total common shares outstanding315879.0339659.0407377.0595159.0857164.01 M28 M48 M48 M48 M
Total net income-17 M-17 M-17 M-8 M-8 M-11 M-14 M-14 M-19 M-19 M
Total ordinary shares49 M49 M49 M49 M49 M49 M49 M49 M49 M49 M
Total revenues213000.0431000.0197000.092000.0437000.0367000.0140000.0163000.0135000.0141000.0
TotalExpenses17 M15 M19 M12 M12 M11 M13 M15 M17 M20 M
TotalRevenue213000.0150000.0197000.092000.0437000.0367000.0140000.0163000.0135000.0141000.0
WriteOff345000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University